标题
Therapeutic Strategies in Huntington’s Disease: From Genetic Defect to Gene Therapy
作者
关键词
-
出版物
Biomedicines
Volume 10, Issue 8, Pages 1895
出版商
MDPI AG
发表日期
2022-08-08
DOI
10.3390/biomedicines10081895
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Small Drugs, Huge Impact: The Extraordinary Impact of Antisense Oligonucleotides in Research and Drug Development
- (2022) Anais M. Quemener et al. MOLECULES
- A novel and accurate full-length HTT mouse model for Huntington’s disease
- (2022) Sushila A Shenoy et al. eLife
- Assessing the Value of Nusinersen for Spinal Muscular Atrophy: A Comparative Analysis of Reimbursement Submission and Appraisal in European Countries
- (2022) Alessandra Blonda et al. Frontiers in Pharmacology
- Polyglutamine Expansion in Huntingtin and Mechanism of DNA Damage Repair Defects in Huntington’s Disease
- (2022) Subrata Pradhan et al. Frontiers in Cellular Neuroscience
- Effects of Creatine Supplementation on Brain Function and Health
- (2022) Scott C. Forbes et al. Nutrients
- Right on target: The next class of efficient, safe, and specific RNAi triggers
- (2022) Jonas Becker et al. Molecular Therapy-Nucleic Acids
- Oxidative Stress in Ischemia/Reperfusion Injuries following Acute Ischemic Stroke
- (2022) Anamaria Jurcau et al. Biomedicines
- Huntington’s disease clinical trials corner: April 2022
- (2022) Carlos Estevez-Fraga et al. Journal of Huntingtons Disease
- Molecular Pathophysiological Mechanisms in Huntington’s Disease
- (2022) Anamaria Jurcau Biomedicines
- The Role of Natural Antioxidants in the Prevention of Dementia—Where Do We Stand and Future Perspectives
- (2021) Anamaria Jurcau Nutrients
- Intrastriatal Administration of AAV5-miHTT in Non-Human Primates and Rats Is Well Tolerated and Results in miHTT Transgene Expression in Key Areas of Huntington Disease Pathology
- (2021) Elisabeth A. Spronck et al. Brain Sciences
- Site-specific incorporation of 5′-methyl DNA enhances the therapeutic profile of gapmer ASOs
- (2021) Guillermo Vasquez et al. NUCLEIC ACIDS RESEARCH
- Altered Gut Microbiota Related to Inflammatory Responses in Patients With Huntington’s Disease
- (2021) Gang Du et al. Frontiers in Immunology
- Power Failure of Mitochondria and Oxidative Stress in Neurodegeneration and Its Computational Models
- (2021) JunHyuk Woo et al. Antioxidants
- A PHASE I CLINICAL TRIAL ON INTRAVENOUS ADMINISTRATION OF IMMATURE HUMAN DENTAL PULP STEM CELLS (NESTACELL HDTM) TO HUNTINGTON'S DISEASE PATIENTS
- (2021) J Macedo et al. CYTOTHERAPY
- Human Huntington’s disease pluripotent stem cell-derived microglia develop normally but are abnormally hyper-reactive and release elevated levels of reactive oxygen species
- (2021) Grace C. O’Regan et al. Journal of Neuroinflammation
- Antisense technology: an overview and prospectus
- (2021) Stanley T. Crooke et al. NATURE REVIEWS DRUG DISCOVERY
- Microglia Activation in Basal Ganglia Is a Late Event in Huntington Disease Pathophysiology
- (2021) Natalia P. Rocha et al. Neurology-Neuroimmunology & Neuroinflammation
- Neuroinflammation in Alzheimer’s Disease
- (2021) Isaac G. Onyango et al. Biomedicines
- New Avenues for the Treatment of Huntington’s Disease
- (2021) Amy Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mitochondrial Abnormalities and Synaptic Damage in Huntington’s Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics
- (2021) Neha Sawant et al. MOLECULAR NEUROBIOLOGY
- Improvements in the Tolerability Profile of 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides in Parallel with Advances in Design, Screening, and Other Methods
- (2021) Wesley Partridge et al. Nucleic Acid Therapeutics
- Cerebral Organoids—Challenges to Establish a Brain Prototype
- (2021) Artem V. Eremeev et al. Cells
- Mechanisms and applications of peptide nucleic acids selectively binding to double‐stranded RNA
- (2021) Xuan Zhan et al. BIOPOLYMERS
- Neuroinflammation in Huntington’s disease: A starring role for astrocyte and microglia
- (2021) Julieta Saba et al. Current Neuropharmacology
- Non-Cell Autonomous and Epigenetic Mechanisms of Huntington’s Disease
- (2021) Chaebin Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies
- (2021) Anamaria Jurcau et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Insights into the Pathogenesis of Neurodegenerative Diseases: Focus on Mitochondrial Dysfunction and Oxidative Stress
- (2021) Anamaria Jurcau INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The acetyltransferase p300 regulates NRF2 stability and localization
- (2020) Athina Ganner et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Oxidative stress in the pathogenesis of Alzheimer’s disease and cerebrovascular disease with therapeutic implications.
- (2020) Anamaria Jurcau et al. CNS & Neurological Disorders-Drug Targets
- Immunotherapies in Huntington's disease and α-Synucleinopathies
- (2020) Oluwaseun Fatoba et al. Frontiers in Immunology
- Antisense Oligonucleotide in LNA-Gapmer Design Targeting TGFBR2—A Key Single Gene Target for Safe and Effective Inhibition of TGFβ Signaling
- (2020) Sabrina Kuespert et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Huntingtin Lowering Strategies
- (2020) Franz Marxreiter et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phosphorothioate modified oligonucleotide–protein interactions
- (2020) Stanley T Crooke et al. NUCLEIC ACIDS RESEARCH
- Mitochondrial and Redox-Based Therapeutic Strategies in Huntington's Disease
- (2020) Lígia Fão et al. ANTIOXIDANTS & REDOX SIGNALING
- AAV5-miHTT gene therapy for Huntington disease: lowering both huntingtins
- (2020) Melvin M. Evers et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Inhibiting cellular uptake of mutant huntingtin using a monoclonal antibody: Implications for the treatment of Huntington's disease
- (2020) Stefan Bartl et al. NEUROBIOLOGY OF DISEASE
- Is the Immunological Response a Bottleneck for Cell Therapy in Neurodegenerative Diseases?
- (2020) Cristina Salado-Manzano et al. Frontiers in Cellular Neuroscience
- Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
- (2020) Sarah J. Tabrizi et al. Nature Reviews Neurology
- Neural Transplants From Human Induced Pluripotent Stem Cells Rescue the Pathology and Behavioral Defects in a Rodent Model of Huntington’s Disease
- (2020) Yongwoo Yoon et al. Frontiers in Neuroscience
- An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington's disease
- (2020) Geraldine Kong et al. NEUROBIOLOGY OF DISEASE
- Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
- (2019) Davide Di Fusco et al. Frontiers in Pharmacology
- Huntingtin Lowering Strategies for Disease Modification in Huntington’s Disease
- (2019) Sarah J. Tabrizi et al. NEURON
- Single synapse indicators of impaired glutamate clearance derived from fast iGluu imaging of cortical afferents in the striatum of normal and Huntington (Q175) mice
- (2019) Anton Dvorzhak et al. JOURNAL OF NEUROSCIENCE
- Significant roles of neuroinflammation in Parkinson’s disease: therapeutic targets for PD prevention
- (2019) Yujeong Lee et al. ARCHIVES OF PHARMACAL RESEARCH
- Targeting Huntingtin Expression in Patients with Huntington’s Disease
- (2019) Sarah J. Tabrizi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease
- (2019) Costanza Ferrari Bardile et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington’s disease
- (2019) Bryan Zeitler et al. NATURE MEDICINE
- Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington’s disease by etanercept treatment
- (2019) Jeffrey Pido-Lopez et al. Scientific Reports
- Suppression of Choroidal Neovascularization by AAV-Based Dual-Acting Antiangiogenic Gene Therapy
- (2019) Anne Louise Askou et al. Molecular Therapy-Nucleic Acids
- CRISPR-Cas9-mediated genome editing increases lifespan and improves motor deficits in a Huntington’s disease mouse model
- (2019) Freja K. Ekman et al. Molecular Therapy-Nucleic Acids
- International Guidelines for the Treatment of Huntington's Disease
- (2019) Anne-Catherine Bachoud-Lévi et al. Frontiers in Neurology
- Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disorders
- (2019) Ana C Silva et al. BRAIN
- Curcumin dietary supplementation ameliorates disease phenotype in an animal model of Huntington’s disease.
- (2019) F Elifani et al. HUMAN MOLECULAR GENETICS
- Potent and sustained huntingtin lowering via AAV5 encoding miRNA preserves striatal volume and cognitive function in a humanized mouse model of Huntington disease
- (2019) Nicholas S Caron et al. NUCLEIC ACIDS RESEARCH
- The Role of Microglia and Astrocytes in Huntington’s Disease
- (2019) Thulani H. Palpagama et al. Frontiers in Molecular Neuroscience
- Antibody-based therapies for Huntington’s disease: current status and future directions
- (2019) Hélèna L. Denis et al. NEUROBIOLOGY OF DISEASE
- AAV5-miHTT Lowers Huntingtin mRNA and Protein without Off-Target Effects in Patient-Derived Neuronal Cultures and Astrocytes
- (2019) Sonay Keskin et al. Molecular Therapy-Methods & Clinical Development
- Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities
- (2018) Rachel J Harding et al. ACTA PHARMACOLOGICA SINICA
- The NAD+-Dependent Family of Sirtuins in Cerebral Ischemia and Preconditioning
- (2018) Nathalie Khoury et al. ANTIOXIDANTS & REDOX SIGNALING
- Disrupted striatal neuron inputs and outputs in Huntington's disease
- (2018) Anton Reiner et al. CNS Neuroscience & Therapeutics
- Cause or compensation?-Altered neuronal Ca2+ handling in Huntington's disease
- (2018) James P. Mackay et al. CNS Neuroscience & Therapeutics
- REST, a master transcriptional regulator in neurodegenerative disease
- (2018) Jee-Yeon Hwang et al. CURRENT OPINION IN NEUROBIOLOGY
- Miro proteins coordinate microtubule‐ and actin‐dependent mitochondrial transport and distribution
- (2018) Guillermo López‐Doménech et al. EMBO JOURNAL
- Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease
- (2018) Oluwaseun Fatoba et al. EXPERIMENTAL NEUROLOGY
- Role of mitochondrial ROS in the brain: from physiology to neurodegeneration
- (2018) Plamena R. Angelova et al. FEBS LETTERS
- Brain-Derived Neurotrophic Factor Prevents Depressive-Like Behaviors in Early-Symptomatic YAC128 Huntington’s Disease Mice
- (2018) Victor Silva da Fonsêca et al. MOLECULAR NEUROBIOLOGY
- Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington’s Disease
- (2018) N. Cabezas-Llobet et al. MOLECULAR NEUROBIOLOGY
- Are immunotherapies for Huntington’s disease a realistic option?
- (2018) Hélèna L. Denis et al. MOLECULAR PSYCHIATRY
- Effect of early embryonic deletion of huntingtin from pyramidal neurons on the development and long-term survival of neurons in cerebral cortex and striatum
- (2018) I. Dragatsis et al. NEUROBIOLOGY OF DISEASE
- Human Umbilical Cord Matrix Stem Cells Reverse Oxidative Stress-Induced Cell Death and Ameliorate Motor Function and Striatal Atrophy in Rat Model of Huntington Disease
- (2018) Mohammad Javad Ebrahimi et al. NEUROTOXICITY RESEARCH
- Increased nuclear DNA damage precedes mitochondrial dysfunction in peripheral blood mononuclear cells from Huntington’s disease patients
- (2018) Georgina Askeland et al. Scientific Reports
- Precise Excision of the CAG Tract from the Huntingtin Gene by Cas9 Nickases
- (2018) Magdalena Dabrowska et al. Frontiers in Neuroscience
- Targeting the proteostasis network in Huntington’s disease
- (2018) Tânia R. Soares et al. AGEING RESEARCH REVIEWS
- Inwardly Rectifying Potassium Channel Kir4.1 as a Novel Modulator of BDNF Expression in Astrocytes
- (2018) Yukihiro Ohno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Quinolinic Acid-Induced Huntington Disease-Like Symptoms Mitigated by Potent Free Radical Scavenger Edaravone—a Pilot Study on Neurobehavioral, Biochemical, and Histological Approach in Male Wistar Rats
- (2018) Thangarajan Sumathi et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- A Sequel to the Eteplirsen Saga: Eteplirsen Is Approved in the United States but Was Not Approved in Europe
- (2018) Annemieke Aartsma-Rus et al. Nucleic Acid Therapeutics
- Nonclinical Development of ANX005: A Humanized Anti-C1q Antibody for Treatment of Autoimmune and Neurodegenerative Diseases
- (2017) Janice A. Lansita et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- The constriction and scission machineries involved in mitochondrial fission
- (2017) Felix Kraus et al. JOURNAL OF CELL SCIENCE
- CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington’s disease
- (2017) Su Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Therapies targeting DNA and RNA in Huntington's disease
- (2017) Edward J Wild et al. LANCET NEUROLOGY
- Transcriptional profiles for distinct aggregation states of mutant Huntingtin exon 1 protein unmask new Huntington's disease pathways
- (2017) Nagaraj S. Moily et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo
- (2017) Alex Mas Monteys et al. MOLECULAR THERAPY
- Molecular basis of selective mitochondrial fusion by heterotypic action between OPA1 and cardiolipin
- (2017) Tadato Ban et al. NATURE CELL BIOLOGY
- A toxic mutant huntingtin species is resistant to selective autophagy
- (2017) Yuhua Fu et al. Nature Chemical Biology
- Unexpected mutations after CRISPR–Cas9 editing in vivo
- (2017) Kellie A Schaefer et al. NATURE METHODS
- Antisense oligonucleotides: the next frontier for treatment of neurological disorders
- (2017) Carlo Rinaldi et al. Nature Reviews Neurology
- The CREST-E study of creatine for Huntington disease
- (2017) Steven M. Hersch et al. NEUROLOGY
- Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases
- (2017) Kathleen M. Schoch et al. NEURON
- Dicer-independent processing of small RNA duplexes: mechanistic insights and applications
- (2017) Elena Herrera-Carrillo et al. NUCLEIC ACIDS RESEARCH
- Unravelling and Exploiting Astrocyte Dysfunction in Huntington’s Disease
- (2017) Baljit S. Khakh et al. TRENDS IN NEUROSCIENCES
- Eteplirsen in the treatment of Duchenne muscular dystrophy
- (2017) Kenji Rowel Lim et al. Drug Design Development and Therapy
- Laquinimod treatment in the R6/2 mouse model
- (2017) Gisa Ellrichmann et al. Scientific Reports
- Microglial Activation in the Pathogenesis of Huntington’s Disease
- (2017) Hui-Ming Yang et al. Frontiers in Aging Neuroscience
- Elimination of huntingtin in the adult mouse leads to progressive behavioral deficits, bilateral thalamic calcification, and altered brain iron homeostasis
- (2017) Paula Dietrich et al. PLoS Genetics
- The Ubiquitination, Disaggregation and Proteasomal Degradation Machineries in Polyglutamine Disease
- (2017) Samir R. Nath et al. Frontiers in Molecular Neuroscience
- Induced Pluripotent Stem Cell-Derived Neural Stem Cell Transplantations Reduced Behavioral Deficits and Ameliorated Neuropathological Changes in YAC128 Mouse Model of Huntington's Disease
- (2017) Abeer Al-Gharaibeh et al. Frontiers in Neuroscience
- Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells
- (2017) Xiaohong Xu et al. Stem Cell Reports
- Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications
- (2017) Jia Liu et al. Frontiers in Immunology
- RNAi mechanisms in Huntington’s disease therapy: siRNA versus shRNA
- (2017) Sebastian Aguiar et al. Translational Neurodegeneration
- The expanded CAG repeat in the huntingtin gene as target for therapeutic RNA modulation throughout the HD mouse brain
- (2017) Nicole A. Datson et al. PLoS One
- Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease Fibroblasts
- (2016) Kyle D. Fink et al. CELL TRANSPLANTATION
- Laquinimod decreases Bax expression and reduces caspase-6 activation in neurons
- (2016) Dagmar E. Ehrnhoefer et al. EXPERIMENTAL NEUROLOGY
- Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific
- (2016) Anne H.P. Jansen et al. GLIA
- Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9
- (2016) Jun Wan Shin et al. HUMAN MOLECULAR GENETICS
- Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells
- (2016) R. Vassena et al. HUMAN REPRODUCTION UPDATE
- Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease
- (2016) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington’s Disease Models
- (2016) Luana Naia et al. MOLECULAR NEUROBIOLOGY
- Deimmunization for gene therapy: host matching of synthetic zinc finger constructs enables long-term mutant Huntingtin repression in mice
- (2016) Carmen Agustín-Pavón et al. Molecular Neurodegeneration
- A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
- (2016) Andrew McGarry et al. NEUROLOGY
- Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
- (2016) Suzan M. Hammond et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies
- (2016) Fernando Pagan et al. Journal of Parkinsons Disease
- The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington’s Disease Mice
- (2016) Haiqun Jia et al. PLoS One
- AMPK activation protects from neuronal dysfunction and vulnerability across nematode, cellular and mouse models of Huntington's disease
- (2015) Rafael P. Vázquez-Manrique et al. HUMAN MOLECULAR GENETICS
- Nonclinical Safety Evaluation of VX15/2503, a Humanized IgG4 Anti-SEMA4D Antibody
- (2015) J. E. Leonard et al. MOLECULAR CANCER THERAPEUTICS
- Huntingtin Haplotypes Provide Prioritized Target Panels for Allele-specific Silencing in Huntington Disease Patients of European Ancestry
- (2015) Chris Kay et al. MOLECULAR THERAPY
- Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers
- (2015) Marios Politis et al. NEUROBIOLOGY OF DISEASE
- Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease
- (2015) Amber L. Southwell et al. NEUROBIOLOGY OF DISEASE
- Triheptanoin improves brain energy metabolism in patients with Huntington disease
- (2015) I. M. Adanyeguh et al. NEUROLOGY
- Developing stem cell therapies for juvenile and adult-onset Huntington's disease
- (2015) Kyle D Fink et al. Regenerative Medicine
- Silencing Mutant Huntingtin by Adeno-Associated Virus-Mediated RNA Interference Ameliorates Disease Manifestations in the YAC128 Mouse Model of Huntington's Disease
- (2014) Lisa M. Stanek et al. HUMAN GENE THERAPY
- Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease
- (2014) Han-Yun Hsiao et al. HUMAN MOLECULAR GENETICS
- A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease
- (2014) Marianne R. Smith et al. HUMAN MOLECULAR GENETICS
- Amitriptyline Improves Motor Function via Enhanced Neurotrophin Signaling and Mitochondrial Functions in the Murine N171-82Q Huntington Disease Model
- (2014) Wei-Na Cong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Transplantation of Induced Pluripotent Stem Cells Improves Functional Recovery in Huntington's Disease Rat Model
- (2014) Shuhua Mu et al. PLoS One
- Allele-Specific Suppression of Mutant Huntingtin Using Antisense Oligonucleotides: Providing a Therapeutic Option for All Huntington Disease Patients
- (2014) Niels H. Skotte et al. PLoS One
- Preventing Formation of Toxic N-Terminal Huntingtin Fragments Through Antisense Oligonucleotide-Mediated Protein Modification
- (2014) Melvin M. Evers et al. Nucleic Acid Therapeutics
- Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms
- (2014) Patrick Pla et al. Frontiers in Behavioral Neuroscience
- Rhes, a Striatal-selective Protein Implicated in Huntington Disease, Binds Beclin-1 and Activates Autophagy
- (2013) Robert G. Mealer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease
- (2013) R. A. Barker et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Chronic blockade of extrasynaptic NMDA receptors ameliorates synaptic dysfunction and pro-death signaling in Huntington disease transgenic mice
- (2013) Alejandro Dau et al. NEUROBIOLOGY OF DISEASE
- Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6/2 mice: behavioral and neuropathological analysis
- (2013) Kyle D Fink et al. Stem Cell Research & Therapy
- Induced pluripotent stem cell-derived neural stem cells: new hope for stroke?
- (2013) Jia Liu Stem Cell Research & Therapy
- Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: Implications in Huntington's disease
- (2012) Rajat Sandhir et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Calpain and STriatal-Enriched protein tyrosine Phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a Huntington's disease mouse model
- (2012) C. M. Gladding et al. HUMAN MOLECULAR GENETICS
- “Huntingtin Holiday”: Progress toward an Antisense Therapy for Huntington's Disease
- (2012) Xiao-Hong Lu et al. NEURON
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
- (2012) Holly B. Kordasiewicz et al. NEURON
- Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6/2 mice
- (2012) M. Garriga-Canut et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adenoviral Astrocyte-Specific Expression of BDNF in the Striata of Mice Transgenic for Huntington’s Disease Delays the Onset of the Motor Phenotype
- (2011) Leticia Arregui et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Neuroprotective and metabolic effects of resveratrol: Therapeutic implications for Huntington's disease and other neurodegenerative disorders
- (2011) Giulio Maria Pasinetti et al. EXPERIMENTAL NEUROLOGY
- Insight into the mechanism of laquinimod action
- (2011) W. Brück et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Targeting Several CAG Expansion Diseases by a Single Antisense Oligonucleotide
- (2011) Melvin M. Evers et al. PLoS One
- The Discovery of Zinc Fingers and Their Applications in Gene Regulation and Genome Manipulation
- (2010) Aaron Klug Annual Review of Biochemistry
- Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease
- (2010) Daniel J. Ho et al. EXPERIMENTAL NEUROLOGY
- Mutant huntingtin impairs Ku70-mediated DNA repair
- (2010) Yasushi Enokido et al. JOURNAL OF CELL BIOLOGY
- Laquinimod suppress antigen presentation in relapsing–remitting multiple sclerosis: In-vitro high-throughput gene expression study
- (2010) M. Gurevich et al. JOURNAL OF NEUROIMMUNOLOGY
- A futility study of minocycline in Huntington's disease
- (2010) Merit Cudkowicz MOVEMENT DISORDERS
- Neural stem cell systems: physiological players or in vitro entities?
- (2010) Luciano Conti et al. NATURE REVIEWS NEUROSCIENCE
- Proteasomal dysfunction in aging and Huntington disease
- (2010) Xiao-Jiang Li et al. NEUROBIOLOGY OF DISEASE
- Nicotinamide improves motor deficits and upregulates PGC-1α and BDNF gene expression in a mouse model of Huntington's disease
- (2010) Tyisha Hathorn et al. NEUROBIOLOGY OF DISEASE
- Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
- (2010) Chiara Zuccato et al. PHYSIOLOGICAL REVIEWS
- Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators
- (2009) Samuel Frank BMC Neurology
- Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins
- (2009) Ferdinando Squitieri et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice
- (2009) M.S. Zajac et al. HIPPOCAMPUS
- CREB is a key regulator of striatal vulnerability in chemical and genetic models of Huntington's disease
- (2009) Yun-Sik Choi et al. NEUROBIOLOGY OF DISEASE
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
- (2008) Salima Hacein-Bey-Abina et al. JOURNAL OF CLINICAL INVESTIGATION
- Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells
- (2008) Xavier Xifró et al. JOURNAL OF NEUROCHEMISTRY
- Polyglutamine-Modulated Striatal Calpain Activity in YAC Transgenic Huntington Disease Mouse Model: Impact on NMDA Receptor Function and Toxicity
- (2008) C. M. Cowan et al. JOURNAL OF NEUROSCIENCE
- Linking SNPs to CAG repeat length in Huntington's disease patients
- (2008) Wanzhao Liu et al. NATURE METHODS
- The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice
- (2008) E. A. Thomas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutant huntingtin and mitochondrial dysfunction
- (2008) Ella Bossy-Wetzel et al. TRENDS IN NEUROSCIENCES
- The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model
- (2007) Qi Peng et al. EXPERIMENTAL NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started